(Q48338057)

10 February 2018

title

Dementia of Parkinson's disease and Alzheimer's disease. Is there a difference? (English)

1 reference

10 February 2018

0 references

0 references

1 reference

1

Stern MB

1 reference

10 February 2018

author name string

Gur RC

series ordinal

2

1 reference

10 February 2018

Saykin AJ

series ordinal

3

1 reference

10 February 2018

Hurtig HI

series ordinal

4

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 June 1986

1 reference

10 February 2018

Journal of the American Geriatrics Society

published in

1 reference

10 February 2018

volume

34

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

475-478

1 reference

10 February 2018

Selective loss of central cholinergic neurons in Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

How common is dementia in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Dementia in Parkinson disease: A neuropathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Basal forebrain neurons in the dementia of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Cognitive deficits in the early stages of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Relationship of motor symptoms to intellectual deficits in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Is ?subcortical dementia? a recognizable clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Confusion, dementia and anticholinergics in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Letter: Long term mental changes in levodopa-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Permanent Dementia in Idiopathic Parkinsonism Treated With Levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

Cholinergic-anticholinergic antagonism in parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1986.TB03416.X

10.1111/J.1532-5415.1986.TB03416.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018